Mml Investors Services, LLC Eli Lilly & CO Transaction History

Mml Investors Services, LLC

  • $27.4 Billion
  • Q3 2024

A detailed history of Mml Investors Services, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Mml Investors Services, LLC holds 122,361 shares of LLY stock, worth $97.4 Million. This represents 0.4% of its overall portfolio holdings.

Number of Shares
122,361
Previous 113,608 7.7%
Holding current value
$97.4 Million
Previous $103 Million 5.39%
% of portfolio
0.4%
Previous 0.42%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$772.14 - $960.02 $6.76 Million - $8.4 Million
8,753 Added 7.7%
122,361 $108 Million
Q2 2024

Aug 14, 2024
SELL
$724.87 - $909.04 $2.21 Million - $2.77 Million
-3,043 Reduced 2.61%
113,608 $103 Million
Q1 2024

May 14, 2024
BUY
$592.2 - $792.28 $4.55 Million - $6.08 Million
7,676 Added 7.04%
116,651 $90.8 Million
Q4 2023

Feb 14, 2024
BUY
$525.19 - $619.13 $10.1 Million - $11.9 Million
19,144 Added 21.31%
108,975 $63.5 Million
Q3 2023

Nov 14, 2023
BUY
$434.7 - $599.3 $31,298 - $43,149
72 Added 0.08%
89,831 $48.3 Million
Q2 2023

Aug 14, 2023
BUY
$350.74 - $468.98 $3.36 Million - $4.49 Million
9,574 Added 11.94%
89,759 $42.1 Million
Q1 2023

May 12, 2023
BUY
$310.63 - $364.82 $2.6 Million - $3.05 Million
8,357 Added 11.63%
80,185 $27.5 Million
Q4 2022

Feb 13, 2023
BUY
$321.55 - $374.67 $3.02 Million - $3.52 Million
9,382 Added 15.02%
71,828 $26.3 Million
Q3 2022

Nov 14, 2022
BUY
$296.48 - $337.87 $2.78 Million - $3.17 Million
9,380 Added 17.68%
62,446 $20.2 Million
Q2 2022

Aug 12, 2022
BUY
$278.73 - $327.27 $2.12 Million - $2.49 Million
7,604 Added 16.73%
53,066 $17.2 Million
Q1 2022

May 13, 2022
BUY
$234.69 - $291.66 $86,131 - $107,039
367 Added 0.81%
45,462 $13 Million
Q4 2021

Feb 14, 2022
BUY
$224.85 - $279.04 $1.19 Million - $1.47 Million
5,274 Added 13.24%
45,095 $12.5 Million
Q3 2021

Nov 15, 2021
BUY
$221.6 - $272.71 $2.32 Million - $2.86 Million
10,476 Added 35.7%
39,821 $9.2 Million
Q2 2021

Aug 13, 2021
BUY
$180.55 - $233.54 $74,025 - $95,751
410 Added 1.42%
29,345 $6.74 Million
Q1 2021

May 14, 2021
BUY
$164.32 - $212.72 $60,634 - $78,493
369 Added 1.29%
28,935 $5.41 Million
Q4 2020

Feb 12, 2021
SELL
$130.46 - $172.63 $400,773 - $530,319
-3,072 Reduced 9.71%
28,566 $4.82 Million
Q3 2020

Nov 13, 2020
SELL
$146.22 - $169.13 $3.24 Million - $3.75 Million
-22,192 Reduced 41.23%
31,638 $4.68 Million
Q2 2020

Aug 14, 2020
BUY
$136.42 - $164.18 $2.64 Million - $3.18 Million
19,359 Added 56.16%
53,830 $8.84 Million
Q1 2020

May 14, 2020
SELL
$119.05 - $147.35 $79,168 - $97,987
-665 Reduced 1.89%
34,471 $4.78 Million
Q4 2019

Feb 11, 2020
BUY
$106.92 - $132.43 $649,859 - $804,909
6,078 Added 20.92%
35,136 $4.62 Million
Q3 2019

Nov 14, 2019
SELL
$106.79 - $116.16 $773,800 - $841,695
-7,246 Reduced 19.96%
29,058 $3.25 Million
Q2 2019

Aug 13, 2019
BUY
$110.79 - $129.32 $121,979 - $142,381
1,101 Added 3.13%
36,304 $4.02 Million
Q1 2019

May 10, 2019
SELL
$111.31 - $131.02 $118,433 - $139,405
-1,064 Reduced 2.93%
35,203 $4.57 Million
Q4 2018

Feb 14, 2019
BUY
$105.9 - $118.64 $1.09 Million - $1.22 Million
10,279 Added 39.55%
36,267 $4.2 Million
Q3 2018

Nov 07, 2018
BUY
$85.86 - $107.31 $660,950 - $826,072
7,698 Added 42.09%
25,988 $2.79 Million
Q2 2018

Aug 13, 2018
SELL
$75.7 - $86.88 $78,122 - $89,660
-1,032 Reduced 5.34%
18,290 $1.56 Million
Q1 2018

May 11, 2018
SELL
$74.21 - $87.6 $405,409 - $478,558
-5,463 Reduced 22.04%
19,322 $1.5 Million
Q4 2017

Feb 13, 2018
BUY
$81.94 - $87.89 $120,287 - $129,022
1,468 Added 6.3%
24,785 $2.09 Million
Q3 2017

Nov 14, 2017
BUY
$77.07 - $85.54 $1.8 Million - $1.99 Million
23,317
23,317 $2 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email